News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
259,995 Results
Type
Article (7247)
Company Profile (68)
Press Release (252679)
Multimedia
Podcasts (13)
Webinars (5)
Section
Business (90642)
Career Advice (533)
Deals (16325)
Drug Delivery (17)
Drug Development (22439)
Employer Resources (39)
FDA (4115)
Job Trends (4533)
News (133373)
Policy (8431)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (424)
Accelerated approval (7)
Adcomms (4)
Allergies (20)
Alliances (17381)
ALS (42)
Alzheimer's disease (339)
Antibody-drug conjugate (ADC) (68)
Approvals (4221)
Artificial intelligence (110)
Autoimmune disease (38)
Automation (8)
Bankruptcy (103)
Best Places to Work (3269)
BIOSECURE Act (2)
Biosimilars (43)
Biotechnology (51)
Bladder cancer (37)
Brain cancer (13)
Breast cancer (141)
Cancer (1168)
Cardiovascular disease (71)
Career advice (453)
Career pathing (4)
CAR-T (94)
CDC (4)
Cell therapy (243)
Cervical cancer (10)
Clinical research (19507)
Collaboration (540)
Company closure (2)
Compensation (428)
Complete response letters (8)
COVID-19 (483)
CRISPR (23)
C-suite (417)
Cystic fibrosis (35)
Data (1722)
Denatured (8)
Depression (31)
Diabetes (91)
Diagnostics (2477)
Digital health (13)
Diversity (3)
Diversity, equity & inclusion (13)
Drug discovery (68)
Drug pricing (23)
Drug shortages (2)
Duchenne muscular dystrophy (74)
Earnings (44944)
Editorial (10)
Employer branding (7)
Employer resources (39)
Events (43935)
Executive appointments (507)
FDA (4967)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (482)
Gene editing (54)
Generative AI (8)
Gene therapy (148)
GLP-1 (193)
Government (578)
Guidances (208)
Healthcare (5581)
HIV (12)
Huntington's disease (10)
IgA nephropathy (24)
Immunology and inflammation (72)
Immuno-oncology (23)
Indications (23)
Infectious disease (527)
Inflammatory bowel disease (49)
Inflation Reduction Act (7)
Influenza (15)
Intellectual property (56)
Interviews (61)
IPO (8407)
IRA (8)
Job creations (1338)
Job search strategy (414)
JPM (8)
Kidney cancer (13)
Labor market (20)
Layoffs (147)
Leadership (8)
Legal (2514)
Liver cancer (26)
Longevity (3)
Lung cancer (121)
Lymphoma (79)
Machine learning (7)
Management (14)
Manufacturing (193)
MASH (64)
Medical device (4169)
Medtech (4180)
Mergers & acquisitions (8410)
Metabolic disorders (281)
Multiple sclerosis (38)
NASH (6)
Neurodegenerative disease (78)
Neuropsychiatric disorders (23)
Neuroscience (685)
NextGen: Class of 2026 (1938)
Non-profit (871)
Now hiring (17)
Obesity (114)
Opinion (50)
Ovarian cancer (44)
Pain (49)
Pancreatic cancer (59)
Parkinson's disease (60)
Partnered (9)
Patents (98)
Patient recruitment (125)
Peanut (7)
People (28443)
Pharmaceutical (12)
Pharmacy benefit managers (2)
Phase 1 (6193)
Phase 2 (8571)
Phase 3 (6587)
Pipeline (2264)
Policy (31)
Postmarket research (653)
Preclinical (2451)
Press Release (66)
Prostate cancer (63)
Psychedelics (6)
Radiopharmaceuticals (120)
Rare diseases (229)
Real estate (2196)
Recruiting (13)
Regulatory (6335)
Reports (20)
Research institute (442)
Resumes & cover letters (78)
Rett syndrome (20)
RNA editing (6)
RSV (3)
Schizophrenia (71)
Series A (89)
Series B (72)
Service/supplier (2)
Sickle cell disease (12)
Special edition (4)
Spinal muscular atrophy (35)
Sponsored (6)
Startups (1391)
Stomach cancer (3)
Supply chain (16)
Tariffs (9)
The Weekly (5)
Vaccines (161)
Venture capital (26)
Weight loss (50)
Women's health (16)
Worklife (1)
Date
Today (7)
Last 7 days (223)
Last 30 days (670)
Last 365 days (10668)
2026 (1182)
2025 (10806)
2024 (12859)
2023 (15274)
2022 (21080)
2021 (22285)
2020 (20313)
2019 (14688)
2018 (11302)
2017 (11338)
2016 (10365)
2015 (13397)
2014 (10606)
2013 (8638)
2012 (9473)
2011 (9783)
2010 (9487)
Location
Africa (223)
Alabama (22)
Alaska (2)
Arizona (89)
Arkansas (1)
Asia (13250)
Australia (1909)
California (4652)
Canada (1299)
China (245)
Colorado (179)
Connecticut (183)
Delaware (76)
Europe (28604)
Florida (594)
Georgia (76)
Hawaii (2)
Idaho (27)
Illinois (183)
India (18)
Indiana (157)
Iowa (9)
Japan (179)
Kansas (48)
Kentucky (18)
Louisiana (8)
Maine (51)
Maryland (390)
Massachusetts (3176)
Michigan (114)
Minnesota (221)
Mississippi (2)
Missouri (37)
Montana (17)
Nebraska (13)
Nevada (49)
New Hampshire (20)
New Jersey (1134)
New Mexico (5)
New York (908)
North Carolina (595)
North Dakota (5)
Northern California (2343)
Ohio (146)
Oklahoma (6)
Oregon (11)
Pennsylvania (683)
Puerto Rico (3)
Rhode Island (21)
South America (311)
South Carolina (18)
Southern California (1801)
Tennessee (66)
Texas (617)
United States (14721)
Utah (115)
Virginia (94)
Washington D.C. (20)
Washington State (361)
West Virginia (3)
Wisconsin (66)
Wyoming (1)
259,995 Results for "valent biosciences corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Rona Therapeutics Unveils the Global First Bi-valent PCSK9-LPA siRNA into Clinical Development for Cardiovascular Risk Reduction
December 18, 2025
·
2 min read
BioMidwest
Valent BioSciences Opens New State-of-the-Art Addition at Melnik and Shafer Biorational Research Center
Valent BioSciences celebrated the grand opening of the new Venburg Wing at the company’s Melnik and Shafer Biorational Research Center in Libertyville, Illinois, during a special ceremony.
May 29, 2024
·
3 min read
Press Releases
BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters Corporation
February 10, 2026
·
5 min read
Press Releases
Systematic Review of 15 Studies Focused on Epidemiology and Antimicrobial Resistance of Pneumococcal Serotypes Covered by CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) in U.S. Adults
October 21, 2025
·
9 min read
Press Releases
CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) Demonstrates Positive Immune Responses in Children and Adolescents at Increased Risk of Pneumococcal Disease
September 11, 2025
·
11 min read
BioMidwest
Sumitomo Chemical and Valent BioSciences Announce Divestiture of Pace International and Future Collaboration with AgroFresh Solutions in the Postharvest Solutions Space
Sumitomo Chemical Co., Ltd. and Valent BioSciences LLC announced that Pace International LLC and its operations overseas will become part of AgroFresh Solutions, Inc., a well-established leader in the postharvest solutions space.
March 27, 2024
·
5 min read
BioMidwest
Valent BioSciences Hosts Sustainability Celebration at Osage Facility
Broadening its commitment to sustainability and corporate social value, Valent BioSciences LLC formally dedicated a new prairie park and solar field adjacent to its manufacturing facility in Osage, Iowa, on June 24.
June 26, 2023
·
4 min read
Press Releases
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - February 3, 2026
February 4, 2026
·
2 min read
Deals
Valent BioSciences Announces the Acquisition of FBSciences
Valent BioSciences LLC announces its acquisition of FBSciences Holdings, Inc., a leader in the discovery and commercialization of naturally derived plant, soil, and climate health solutions.
January 30, 2023
·
5 min read
Drug Development
SK bioscience-Sanofi Announce Positive Results from Phase II Study of 21-Valent Pneumococcal Conjugate Vaccine Candidate
SK bioscience announced positive results from its Phase II clinical trials in infants of its 21-valent pneumococcal conjugate vaccine candidate, ‘GBP410', evaluating its safety and immunogenicity.
June 29, 2023
·
4 min read
1 of 26,000
Next
